Literature DB >> 21136031

A randomized prospective study of rehabilitation therapy in the treatment of radiation-induced dysphagia and trismus.

Y Tang1, Q Shen, Y Wang, K Lu, Y Wang, Y Peng.   

Abstract

PURPOSE: To evaluate the therapeutic effect of rehabilitation therapy on radiation-induced dysphagia and trismus in nasopharyngeal carcinoma (NPC) patients after radiotherapy. PATIENTS AND METHODS: 43 NPC patients after radiotherapy were included. Patients were randomly assigned to either the rehabilitation group or a control group. Both groups were subjected to routine treatment, while the rehabilitation group also received rehabilitation therapy for 3 months. The severity of dysphagia was assessed using the water swallow test, while trismus was evaluated with the LENT/SOMA score and the interincisor distance (IID). The water swallow test, the LENT/SOMA score, as well as IID for both groups before and after treatment were analyzed and compared.
RESULTS: After treatment, the rehabilitation group displayed a significant improvement in swallowing function, while the control group did not. The efficacy rate (percentage of patients with excellent or effective results) of rehabilitation group was higher than that of control group (77% vs. 43%), and the difference was statistically significant (ϰ(2) = 5.32, p = 0.02). IID pretreatment and posttreatment did not show much difference in the rehabilitation group, while in the control group IID significantly decreased posttreatment (1.1 ± 0.36 cm vs.1.8 ± 0.56 cm, p = 0.001). Although the mean IID in patients of both groups decreased after the 3 month follow-up, the decrease in the rehabilitation group was less than that of the control group (0.19 ± 0.5 cm vs. 0.69 ± 0.56 cm, p = 0.004 ). The efficacy rate of trismus in the rehabilitation group was significantly higher than that of the control group (64% vs. 28%, ϰ(2) = 5.31, p = 0.02).
CONCLUSIONS: Rehabilitation training can improve swallow function and slow down the progress of trismus in NPC patients following radiotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 21136031     DOI: 10.1007/s00066-010-2151-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  26 in total

1.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

2.  Evaluation of side effects after radiotherapy in childhood and adolescence: from retrospective case reports to a prospective, multicentric and transnational approach.

Authors:  Normann Willich; Iris Ernst; Hildegard Pape; Christian Rübe; Beate Timmermann; Branka Asadpour; Rolf-Dieter Kortmann; Tobias Bölling
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

3.  High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer.

Authors:  Hendrik Andreas Wolff; Jan Bosch; Klaus Jung; Tobias Overbeck; Steffen Hennies; Christoph Matthias; Clemens F Hess; Ralph M Roedel; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

4.  LENT SOMA scales for all anatomic sites.

Authors: 
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

5.  Impact of dysphagia on quality of life after treatment of head-and-neck cancer.

Authors:  Nam P Nguyen; Cheryl Frank; Candace C Moltz; Paul Vos; Herbert J Smith; Ulf Karlsson; Suresh Dutta; Allan Midyett; Jessica Barloon; Sabah Sallah
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

6.  Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities.

Authors:  Barbara Roa Pauloski; Alfred W Rademaker; Cathy Lazarus; Guy Boeckxstaens; Peter J Kahrilas; Jerilyn A Logemann
Journal:  Dysphagia       Date:  2008-10-28       Impact factor: 3.438

7.  Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.

Authors:  Panagiotis Balermpas; Markus Hambek; Oliver Seitz; Claus Rödel; Christian Weiss
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

8.  Aspiration occurence during chemoradiation for head and neck cancer.

Authors:  Nam P Nguyen; Herbert J Smith; Suresh Dutta; Alan Alfieri; Debra North; Phuc D Nguyen; Howard Lee; Tomas Martinez; Claire Lemanski; Adir Ludin; Ly M Nguyen; Sabah Sallah
Journal:  Anticancer Res       Date:  2007 May-Jun       Impact factor: 2.480

Review 9.  Nasopharyngeal carcinoma: current management, future directions and dental implications.

Authors:  Mark Agulnik; Joel B Epstein
Journal:  Oral Oncol       Date:  2007-12-03       Impact factor: 5.337

10.  Normal-tissue radioprotection by overexpression of the copper-zinc and manganese superoxide dismutase genes.

Authors:  Marlon R Veldwijk; Carsten Herskind; Leopold Sellner; Aleksandar Radujkovic; Stephanie Laufs; Stefan Fruehauf; W Jens Zeller; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

View more
  35 in total

1.  [Potential of adipose-derived stem cells concerning the treatment of wound healing complications after radiotherapy].

Authors:  F Haubner; H G Gassner
Journal:  HNO       Date:  2015-02       Impact factor: 1.284

Review 2.  Treatment of late sequelae after radiotherapy for head and neck cancer.

Authors:  Primož Strojan; Katherine A Hutcheson; Avraham Eisbruch; Jonathan J Beitler; Johannes A Langendijk; Anne W M Lee; June Corry; William M Mendenhall; Robert Smee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Cancer Treat Rev       Date:  2017-07-18       Impact factor: 12.111

3.  Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer.

Authors:  Shyam D Rao; Ziad H Saleh; Jeremy Setton; Moses Tam; Sean M McBride; Nadeem Riaz; Joseph O Deasy; Nancy Y Lee
Journal:  Acta Oncol       Date:  2015-04-29       Impact factor: 4.089

4.  Impact of Compliance on Dysphagia Rehabilitation in Head and Neck Cancer Patients: Results from a Multi-center Clinical Trial.

Authors:  Gintas P Krisciunas; Kerlly Castellano; Timothy M McCulloch; Cathy L Lazarus; Barbara R Pauloski; Tanya K Meyer; Darlene Graner; Douglas J Van Daele; Alice K Silbergleit; Lisa R Crujido; Denis Rybin; Gheorghe Doros; Tamar Kotz; Susan E Langmore
Journal:  Dysphagia       Date:  2016-11-16       Impact factor: 3.438

Review 5.  Clinical review of physical activity and functional considerations in head and neck cancer patients.

Authors:  Klaudia U Hunter; Shruti Jolly
Journal:  Support Care Cancer       Date:  2013-02-17       Impact factor: 3.603

Review 6.  Therapeutic exercises for affecting post-treatment swallowing in people treated for advanced-stage head and neck cancers.

Authors:  Alison Perry; Siew Hwa Lee; Susan Cotton; Catriona Kennedy
Journal:  Cochrane Database Syst Rev       Date:  2016-08-26

Review 7.  Therapeutic intervention in oropharyngeal dysphagia.

Authors:  Rosemary Martino; Timothy McCulloch
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

8.  Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.

Authors:  L Deantonio; L Masini; M Brambilla; F Pia; M Krengli
Journal:  Strahlenther Onkol       Date:  2013-01-16       Impact factor: 3.621

9.  Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapy.

Authors:  David N Teguh; Peter C Levendag; Wendimagegn Ghidey; Kees van Montfort; Stefan L S Kwa
Journal:  Dysphagia       Date:  2013-01-26       Impact factor: 3.438

10.  Success of endoscopic pharyngoesophageal dilation after head and neck cancer treatment.

Authors:  Claudia I Chapuy; Donald J Annino; Roy B Tishler; Robert I Haddad; Anna Snavely; Laura A Goguen
Journal:  Laryngoscope       Date:  2013-07-08       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.